The Board of Directors of Suven Life Sciences Limited, at its meeting held today i.e. 9th March, 2019, has taken on record the approval for creation of Wholly Owned Subsidiary (WOS) Suven Pharma, Inc a Delaware Company in USA under CRAMS Division.
The board also approved investment of 75 Mn USD in the said WOS for new business opportunities and acquisitions etc.
Shares of SUVEN LIFE SCIENCES LTD. was last trading in BSE at Rs.265.1 as compared to the previous close of Rs. 266.8. The total number of shares traded during the day was 82421 in over 1534 trades.
The stock hit an intraday high of Rs. 275 and intraday low of 263.8. The net turnover during the day was Rs. 22121105.